COVID-19 & Ohio: Economic Recovery, Case Increases and More
April 13, 2021
Today, Governor Mike DeWine and Lt. Governor Jon Husted provided an update on Ohio's vaccination plans following this morning's decision to pause the administration of the Johnson and Johnson (Janssen) vaccine.
The majority of the Ohio's Johnson and Johnson doses were directed to mass vaccination clinics and to 63 public and private 4-year colleges and universities, most of which have already completed their student vaccinations.
Of the mass vaccination clinics and college/university clinics that did plan to offer the Johnson and Johnson vaccine this week, most will proceed with their clinics by offering either the Pfizer or Moderna vaccine. A total of eight sites will not offer any vaccines this week as the health community works to recognize, report and manage any adverse events related to the Johnson and Johnson vaccine.
There are many other local providers with open appointments for the Pfizer or Moderna vaccine. Visit gettheshot.coronavirus.ohio.gov to look for open appointments.
DeWine, Ohio Department of Health Director Stephanie McCloud and Ohio Department of Health Chief Medical Officer Bruce Vanderhoff, M.D., directed all Ohio vaccine providers this morning to temporarily pause using the Johnson and Johnson vaccine following a recommendation by the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC). The recommendation was made after six people who received the Johnson and Johnson vaccine experienced an extremely rare blood-clotting condition in the United States. The cases have occurred in women between 18 and 48 and the reactions have taken place within 6-13 days after receiving the vaccine.
Approximately 6.8 million people have received the Johnson and Johnson vaccine in the U.S. 264,311 of those vaccinations were administered in Ohio.